RVNC - Revance Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts8888
Avg. Estimate-0.91-0.96-3.75-3.7
Low Estimate-1.03-1.06-4.13-4.45
High Estimate-0.8-0.87-3.5-2.4
Year Ago EPS-0.94-0.91-3.94-3.75
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts109109
Avg. Estimate710k610k2.38M25.17M
Low EstimateN/AN/A300k770k
High Estimate2M2M6.28M56.81M
Year Ago Sales686k2.36M3.73M2.38M
Sales Growth (year/est)3.50%-74.20%-36.20%957.60%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.94-0.97-0.94-0.87
EPS Actual-0.94-0.91-1.12-0.85
Difference00.06-0.180.02
Surprise %0.00%6.20%-19.10%2.30%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.91-0.96-3.75-3.7
7 Days Ago-0.91-0.96-3.75-3.7
30 Days Ago-0.92-0.97-3.75-3.89
60 Days Ago-0.9-0.96-3.71-3.64
90 Days Ago-0.9-0.95-3.68-3.4
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRVNCIndustrySectorS&P 500
Current Qtr.3.20%N/AN/A0.01
Next Qtr.-5.50%N/AN/A0.02
Current Year4.80%N/AN/A0.04
Next Year1.30%N/AN/A0.10
Next 5 Years (per annum)11.60%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A